Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Tasigna Drug Market 2018, Forecast to 2023

July 2018 | 119 pages | ID: GF7291C0E86EN
GlobalInfoResearch

Abstracts

Nilotinib in the form of the hydrochloride monohydrate salt, is a small-molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia.

Scope of the Report:

This report focuses on the Tasigna Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Tasigna Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• Novartis

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• 50mg
• 200mg
• Other

Market Segment by Applications, can be divided into

• Hospital
• Drugs Store
• Other

There are 15 Chapters to deeply display the global Tasigna Drug market.
Chapter 1, to describe Tasigna Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Tasigna Drug, with sales, revenue, and price of Tasigna Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Tasigna Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Tasigna Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Tasigna Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Tasigna Drug Introduction
1.2 Market Analysis by Type
  1.2.1 50mg
  1.2.2 200mg
  1.2.3 Other
1.3 Market Analysis by Applications
  1.3.1 Hospital
  1.3.2 Drugs Store
  1.3.3 Other
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Novartis
  2.1.1 Business Overview
    2.1.1.1 Novartis Description
    2.1.1.2 Novartis Headquarter, Main Business and Finance Overview
  2.1.2 Novartis Tasigna Drug Product Introduction
    2.1.2.1 Tasigna Drug Production Bases, Sales Regions and Major Competitors
    2.1.2.2 Tasigna Drug Product Information
  2.1.3 Novartis Tasigna Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.1 Novartis Tasigna Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.2 Global Novartis Tasigna Drug Market Share in 2017

3 GLOBAL TASIGNA DRUG MARKET COMPETITION, BY MANUFACTURER

3.1 Global Tasigna Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Tasigna Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Tasigna Drug Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Tasigna Drug Manufacturer Market Share in 2017
  3.4.2 Top 5 Tasigna Drug Manufacturer Market Share in 2017
3.5 Market Competition Trend

4 GLOBAL TASIGNA DRUG MARKET ANALYSIS BY REGIONS

4.1 Global Tasigna Drug Sales, Revenue and Market Share by Regions
  4.1.1 Global Tasigna Drug Sales by Regions (2013-2018)
  4.1.2 Global Tasigna Drug Revenue by Regions (2013-2018)
4.2 North America Tasigna Drug Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Tasigna Drug Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Tasigna Drug Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Tasigna Drug Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Tasigna Drug Sales, Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA TASIGNA DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 North America Tasigna Drug Sales, Revenue and Market Share by Countries
  5.1.1 North America Tasigna Drug Sales by Countries (2013-2018)
  5.1.2 North America Tasigna Drug Revenue by Countries (2013-2018)
  5.1.3 United States Tasigna Drug Sales and Growth Rate (2013-2018)
  5.1.4 Canada Tasigna Drug Sales and Growth Rate (2013-2018)
  5.1.5 Mexico Tasigna Drug Sales and Growth Rate (2013-2018)
5.2 North America Tasigna Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
  5.2.1 North America Tasigna Drug Sales by Manufacturers (2016-2017)
  5.2.2 North America Tasigna Drug Revenue by Manufacturers (2016-2017)
5.3 North America Tasigna Drug Sales, Revenue and Market Share by Type (2013-2018)
  5.3.1 North America Tasigna Drug Sales and Sales Share by Type (2013-2018)
  5.3.2 North America Tasigna Drug Revenue and Revenue Share by Type (2013-2018)
5.4 North America Tasigna Drug Sales, Revenue and Market Share by Application (2013-2018)
  5.4.1 North America Tasigna Drug Sales and Sales Share by Application (2013-2018)
  5.4.2 North America Tasigna Drug Revenue and Revenue Share by Application (2013-2018)

6 EUROPE TASIGNA DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Europe Tasigna Drug Sales, Revenue and Market Share by Countries
  6.1.1 Europe Tasigna Drug Sales by Countries (2013-2018)
  6.1.2 Europe Tasigna Drug Revenue by Countries (2013-2018)
  6.1.3 Germany Tasigna Drug Sales and Growth Rate (2013-2018)
  6.1.4 UK Tasigna Drug Sales and Growth Rate (2013-2018)
  6.1.5 France Tasigna Drug Sales and Growth Rate (2013-2018)
  6.1.6 Russia Tasigna Drug Sales and Growth Rate (2013-2018)
  6.1.7 Italy Tasigna Drug Sales and Growth Rate (2013-2018)
6.2 Europe Tasigna Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
  6.2.1 Europe Tasigna Drug Sales by Manufacturers (2016-2017)
  6.2.2 Europe Tasigna Drug Revenue by Manufacturers (2016-2017)
6.3 Europe Tasigna Drug Sales, Revenue and Market Share by Type (2013-2018)
  6.3.1 Europe Tasigna Drug Sales and Sales Share by Type (2013-2018)
  6.3.2 Europe Tasigna Drug Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Tasigna Drug Sales, Revenue and Market Share by Application (2013-2018)
  6.4.1 Europe Tasigna Drug Sales and Sales Share by Application (2013-2018)
  6.4.2 Europe Tasigna Drug Revenue and Revenue Share by Application (2013-2018)

7 ASIA-PACIFIC TASIGNA DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Asia-Pacific Tasigna Drug Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Tasigna Drug Sales by Countries (2013-2018)
  7.1.2 Asia-Pacific Tasigna Drug Revenue by Countries (2013-2018)
  7.1.3 China Tasigna Drug Sales and Growth Rate (2013-2018)
  7.1.4 Japan Tasigna Drug Sales and Growth Rate (2013-2018)
  7.1.5 Korea Tasigna Drug Sales and Growth Rate (2013-2018)
  7.1.6 India Tasigna Drug Sales and Growth Rate (2013-2018)
  7.1.7 Southeast Asia Tasigna Drug Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Tasigna Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
  7.2.1 Asia-Pacific Tasigna Drug Sales by Manufacturers (2016-2017)
  7.2.2 Asia-Pacific Tasigna Drug Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Tasigna Drug Sales, Revenue and Market Share by Type (2013-2018)
  7.3.1 Asia-Pacific Tasigna Drug Sales and Sales Share by Type (2013-2018)
  7.3.2 Asia-Pacific Tasigna Drug Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Tasigna Drug Sales, Revenue and Market Share by Application (2013-2018)
  7.4.1 Asia-Pacific Tasigna Drug Sales and Sales Share by Application (2013-2018)
  7.4.2 Asia-Pacific Tasigna Drug Revenue and Revenue Share by Application (2013-2018)

8 SOUTH AMERICA TASIGNA DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

8.1 South America Tasigna Drug Sales, Revenue and Market Share by Countries
  8.1.1 South America Tasigna Drug Sales by Countries (2013-2018)
  8.1.2 South America Tasigna Drug Revenue by Countries (2013-2018)
  8.1.3 Brazil Tasigna Drug Sales and Growth Rate (2013-2018)
  8.1.4 Argentina Tasigna Drug Sales and Growth Rate (2013-2018)
  8.1.5 Colombia Tasigna Drug Sales and Growth Rate (2013-2018)
8.2 South America Tasigna Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
  8.2.1 South America Tasigna Drug Sales by Manufacturers (2016-2017)
  8.2.2 South America Tasigna Drug Revenue by Manufacturers (2016-2017)
8.3 South America Tasigna Drug Sales, Revenue and Market Share by Type (2013-2018)
  8.3.1 South America Tasigna Drug Sales and Sales Share by Type (2013-2018)
  8.3.2 South America Tasigna Drug Revenue and Revenue Share by Type (2013-2018)
8.4 South America Tasigna Drug Sales, Revenue and Market Share by Application (2013-2018)
  8.4.1 South America Tasigna Drug Sales and Sales Share by Application (2013-2018)
  8.4.2 South America Tasigna Drug Revenue and Revenue Share by Application (2013-2018)

9 MIDDLE EAST AND AFRICA TASIGNA DRUG BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

9.1 Middle East and Africa Tasigna Drug Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Tasigna Drug Sales by Countries (2013-2018)
  9.1.2 Middle East and Africa Tasigna Drug Revenue by Countries (2013-2018)
  9.1.3 Saudi Arabia Tasigna Drug Sales and Growth Rate (2013-2018)
  9.1.4 UAE Tasigna Drug Sales and Growth Rate (2013-2018)
  9.1.5 Egypt Tasigna Drug Sales and Growth Rate (2013-2018)
  9.1.6 Nigeria Tasigna Drug Sales and Growth Rate (2013-2018)
  9.1.7 South Africa Tasigna Drug Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Tasigna Drug Sales and Revenue (Value) by Manufacturers (2016-2017)
  9.2.1 Middle East and Africa Tasigna Drug Sales by Manufacturers (2016-2017)
  9.2.2 Middle East and Africa Tasigna Drug Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Tasigna Drug Sales, Revenue and Market Share by Type (2013-2018)
  9.3.1 Middle East and Africa Tasigna Drug Sales and Sales Share by Type (2013-2018)
  9.3.1 Middle East and Africa Tasigna Drug Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Tasigna Drug Sales, Revenue and Market Share by Application (2013-2018)
  9.4.1 Middle East and Africa Tasigna Drug Sales and Sales Share by Application (2013-2018)
  9.4.2 Middle East and Africa Tasigna Drug Revenue and Revenue Share by Application (2013-2018)

10 GLOBAL TASIGNA DRUG MARKET SEGMENT BY TYPE

10.1 Global Tasigna Drug Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Tasigna Drug Sales and Market Share by Type (2013-2018)
  10.1.2 Global Tasigna Drug Revenue and Market Share by Type (2013-2018)
10.2 50mg Sales Growth and Price
  10.2.1 Global 50mg Sales Growth (2013-2018)
  10.2.2 Global 50mg Price (2013-2018)
10.3 200mg Sales Growth and Price
  10.3.1 Global 200mg Sales Growth (2013-2018)
  10.3.2 Global 200mg Price (2013-2018)
10.4 Other Sales Growth and Price
  10.4.1 Global Other Sales Growth (2013-2018)
  10.4.2 Global Other Price (2013-2018)

11 GLOBAL TASIGNA DRUG MARKET SEGMENT BY APPLICATION

11.1 Global Tasigna Drug Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Drugs Store Sales Growth (2013-2018)
11.4 Other Sales Growth (2013-2018)

12 TASIGNA DRUG MARKET FORECAST (2018-2023)

12.1 Global Tasigna Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Tasigna Drug Market Forecast by Regions (2018-2023)
  12.2.1 North America Tasigna Drug Market Forecast (2018-2023)
  12.2.2 Europe Tasigna Drug Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Tasigna Drug Market Forecast (2018-2023)
  12.2.4 South America Tasigna Drug Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Tasigna Drug Market Forecast (2018-2023)
12.3 Tasigna Drug Market Forecast by Type (2018-2023)
  12.3.1 Global Tasigna Drug Sales Forecast by Type (2018-2023)
  12.3.2 Global Tasigna Drug Market Share Forecast by Type (2018-2023)
12.4 Tasigna Drug Market Forecast by Application (2018-2023)
  12.4.1 Global Tasigna Drug Sales Forecast by Application (2018-2023)
  12.4.2 Global Tasigna Drug Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Tasigna Drug Picture
Table Product Specifications of Tasigna Drug
Figure Global Tasigna Drug CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Tasigna Drug CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Tasigna Drug by Types in 2017
Figure 50mg Picture
Table Major Manufacturers of 50mg
Figure 200mg Picture
Table Major Manufacturers of 200mg
Figure Other Picture
Table Major Manufacturers of Other
Figure Tasigna Drug Sales Market Share by Applications in 2017
Figure Hospital Picture
Figure Drugs Store Picture
Figure Other Picture
Figure United States Tasigna Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Tasigna Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Tasigna Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Tasigna Drug Revenue (Value) and Growth Rate (2013-2023)
Figure France Tasigna Drug Revenue (Value) and Growth Rate (2013-2023)
Figure UK Tasigna Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Tasigna Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Tasigna Drug Revenue (Value) and Growth Rate (2013-2023)
Figure China Tasigna Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Tasigna Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Tasigna Drug Revenue (Value) and Growth Rate (2013-2023)
Figure India Tasigna Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Tasigna Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Tasigna Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Tasigna Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Tasigna Drug Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Tasigna Drug Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Tasigna Drug Revenue (Value) and Growth Rate (2013-2023)
Table Novartis Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis Tasigna Drug Production Bases, Sales Regions and Major Competitors
Table Novartis Tasigna Drug Product
Table Novartis Tasigna Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis Tasigna Drug Sales Market Share in 2017
Figure Global Novartis Tasigna Drug Revenue Market Share in 2017
Table Global Tasigna Drug Sales by Manufacturer (2016-2017)
Figure Global Tasigna Drug Sales Market Share by Manufacturer in 2016
Figure Global Tasigna Drug Sales Market Share by Manufacturer in 2017
Table Global Tasigna Drug Revenue by Manufacturer (2016-2017)
Figure Global Tasigna Drug Revenue Market Share by Manufacturer in 2016
Figure Global Tasigna Drug Revenue Market Share by Manufacturer in 2017
Table Global Tasigna Drug Price by Manufacturer (2016-2017)
Figure Top 3 Tasigna Drug Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Tasigna Drug Manufacturer (Revenue) Market Share in 2017
Figure Global Tasigna Drug Sales and Growth Rate (2013-2018)
Figure Global Tasigna Drug Revenue and Growth Rate (2013-2018)
Table Global Tasigna Drug Sales by Regions (2013-2018)
Table Global Tasigna Drug Sales Market Share by Regions (2013-2018)
Table Global Tasigna Drug Revenue by Regions (2013-2018)
Figure Global Tasigna Drug Revenue Market Share by Regions in 2013
Figure Global Tasigna Drug Revenue Market Share by Regions in 2017
Figure North America Tasigna Drug Sales and Growth Rate (2013-2018)
Figure North America Tasigna Drug Revenue and Growth Rate (2013-2018)
Figure Europe Tasigna Drug Sales and Growth Rate (2013-2018)
Figure Europe Tasigna Drug Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Tasigna Drug Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Tasigna Drug Revenue and Growth Rate (2013-2018)
Figure South America Tasigna Drug Sales and Growth Rate (2013-2018)
Figure South America Tasigna Drug Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Tasigna Drug Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Tasigna Drug Revenue and Growth Rate (2013-2018)
Figure North America Tasigna Drug Revenue and Growth Rate (2013-2018)
Table North America Tasigna Drug Sales by Countries (2013-2018)
Table North America Tasigna Drug Sales Market Share by Countries (2013-2018)
Figure North America Tasigna Drug Sales Market Share by Countries in 2013
Figure North America Tasigna Drug Sales Market Share by Countries in 2017
Table North America Tasigna Drug Revenue by Countries (2013-2018)
Table North America Tasigna Drug Revenue Market Share by Countries (2013-2018)
Figure North America Tasigna Drug Revenue Market Share by Countries in 2013
Figure North America Tasigna Drug Revenue Market Share by Countries in 2017
Figure United States Tasigna Drug Sales and Growth Rate (2013-2018)
Figure Canada Tasigna Drug Sales and Growth Rate (2013-2018)
Figure Mexico Tasigna Drug Sales and Growth Rate (2013-2018)
Table North America Tasigna Drug Sales by Manufacturer (2016-2017)
Figure North America Tasigna Drug Sales Market Share by Manufacturer in 2016
Figure North America Tasigna Drug Sales Market Share by Manufacturer in 2017
Table North America Tasigna Drug Revenue by Manufacturer (2016-2017)
Figure North America Tasigna Drug Revenue Market Share by Manufacturer in 2016
Figure North America Tasigna Drug Revenue Market Share by Manufacturer in 2017
Table North America Tasigna Drug Sales by Type (2013-2018)
Table North America Tasigna Drug Sales Share by Type (2013-2018)
Table North America Tasigna Drug Revenue by Type (2013-2018)
Table North America Tasigna Drug Revenue Share by Type (2013-2018)
Table North America Tasigna Drug Sales by Application (2013-2018)
Table North America Tasigna Drug Sales Share by Application (2013-2018)
Table North America Tasigna Drug Revenue by Application (2013-2018)
Table North America Tasigna Drug Revenue Share by Application (2013-2018)
Figure Europe Tasigna Drug Revenue and Growth Rate (2013-2018)
Table Europe Tasigna Drug Sales by Countries (2013-2018)
Table Europe Tasigna Drug Sales Market Share by Countries (2013-2018)
Table Europe Tasigna Drug Revenue by Countries (2013-2018)
Figure Europe Tasigna Drug Revenue Market Share by Countries in 2016
Figure Europe Tasigna Drug Revenue Market Share by Countries in 2017
Figure Germany Tasigna Drug Sales and Growth Rate (2013-2018)
Figure UK Tasigna Drug Sales and Growth Rate (2013-2018)
Figure France Tasigna Drug Sales and Growth Rate (2013-2018)
Figure Russia Tasigna Drug Sales and Growth Rate (2013-2018)
Figure Italy Tasigna Drug Sales and Growth Rate (2013-2018)
Table Europe Tasigna Drug Sales by Manufacturer (2016-2017)
Figure Europe Tasigna Drug Sales Market Share by Manufacturer in 2016
Figure Europe Tasigna Drug Sales Market Share by Manufacturer in 2017
Table Europe Tasigna Drug Revenue by Manufacturer (2016-2017)
Figure Europe Tasigna Drug Revenue Market Share by Manufacturer in 2016
Figure Europe Tasigna Drug Revenue Market Share by Manufacturer in 2017
Table Europe Tasigna Drug Sales by Type (2013-2018)
Table Europe Tasigna Drug Sales Share by Type (2013-2018)
Table Europe Tasigna Drug Revenue by Type (2013-2018)
Table Europe Tasigna Drug Revenue Share by Type (2013-2018)
Table Europe Tasigna Drug Sales by Application (2013-2018)
Table Europe Tasigna Drug Sales Share by Application (2013-2018)
Table Europe Tasigna Drug Revenue by Application (2013-2018)
Table Europe Tasigna Drug Revenue Share by Application (2013-2018)
Figure Asia-Pacific Tasigna Drug Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Tasigna Drug Sales by Countries (2013-2018)
Table Asia-Pacific Tasigna Drug Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Tasigna Drug Sales Market Share by Countries 2017
Table Asia-Pacific Tasigna Drug Revenue by Countries (2013-2018)
Figure Asia-Pacific Tasigna Drug Revenue Market Share by Countries 2017
Figure China Tasigna Drug Sales and Growth Rate (2013-2018)
Figure Japan Tasigna Drug Sales and Growth Rate (2013-2018)
Figure Korea Tasigna Drug Sales and Growth Rate (2013-2018)
Figure India Tasigna Drug Sales and Growth Rate (2013-2018)
Figure Southeast Asia Tasigna Drug Sales and Growth Rate (2013-2018)
Table Asia-Pacific Tasigna Drug Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Tasigna Drug Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Tasigna Drug Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Tasigna Drug Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Tasigna Drug Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Tasigna Drug Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Tasigna Drug Sales by Type (2013-2018)
Table Asia-Pacific Tasigna Drug Sales Share by Type (2013-2018)
Table Asia-Pacific Tasigna Drug Revenue by Type (2013-2018)
Table Asia-Pacific Tasigna Drug Revenue Share by Type (2013-2018)
Table Asia-Pacific Tasigna Drug Sales by Application (2013-2018)
Table Asia-Pacific Tasigna Drug Sales Share by Application (2013-2018)
Table Asia-Pacific Tasigna Drug Revenue by Application (2013-2018)
Table Asia-Pacific Tasigna Drug Revenue Share by Application (2013-2018)
Figure South America Tasigna Drug Revenue and Growth Rate (2013-2018)
Table South America Tasigna Drug Sales by Countries (2013-2018)
Table South America Tasigna Drug Sales Market Share by Countries (2013-2018)
Figure South America Tasigna Drug Sales Market Share by Countries in 2017
Table South America Tasigna Drug Revenue by Countries (2013-2018)
Table South America Tasigna Drug Revenue Market Share by Countries (2013-2018)
Figure South America Tasigna Drug Revenue Market Share by Countries in 2017
Figure Brazil Tasigna Drug Sales and Growth Rate (2013-2018)
Figure Argentina Tasigna Drug Sales and Growth Rate (2013-2018)
Figure Colombia Tasigna Drug Sales and Growth Rate (2013-2018)
Table South America Tasigna Drug Sales by Manufacturer (2016-2017)
Figure South America Tasigna Drug Sales Market Share by Manufacturer in 2016
Figure South America Tasigna Drug Sales Market Share by Manufacturer in 2017
Table South America Tasigna Drug Revenue by Manufacturer (2016-2017)
Figure South America Tasigna Drug Revenue Market Share by Manufacturer in 2016
Figure South America Tasigna Drug Revenue Market Share by Manufacturer in 2017
Table South America Tasigna Drug Sales by Type (2013-2018)
Table South America Tasigna Drug Sales Share by Type (2013-2018)
Table South America Tasigna Drug Revenue by Type (2013-2018)
Table South America Tasigna Drug Revenue Share by Type (2013-2018)
Table South America Tasigna Drug Sales by Application (2013-2018)
Table South America Tasigna Drug Sales Share by Application (2013-2018)
Table South America Tasigna Drug Revenue by Application (2013-2018)
Table South America Tasigna Drug Revenue Share by Application (2013-2018)
Figure Middle East and Africa Tasigna Drug Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Tasigna Drug Sales by Countries (2013-2018)
Table Middle East and Africa Tasigna Drug Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Tasigna Drug Sales Market Share by Countries in 2017
Table Middle East and Africa Tasigna Drug Revenue by Countries (2013-2018)
Table Middle East and Africa Tasigna Drug Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Tasigna Drug Revenue Market Share by Countries in 2013
Figure Middle East and Africa Tasigna Drug Revenue Market Share by Countries in 2017
Figure Saudi Arabia Tasigna Drug Sales and Growth Rate (2013-2018)
Figure UAE Tasigna Drug Sales and Growth Rate (2013-2018)
Figure Egypt Tasigna Drug Sales and Growth Rate (2013-2018)
Figure Nigeria Tasigna Drug Sales and Growth Rate (2013-2018)
Figure South Africa Tasigna Drug Sales and Growth Rate (2013-2018)
Table Middle East and Africa Tasigna Drug Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Tasigna Drug Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Tasigna Drug Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Tasigna Drug Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Tasigna Drug Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Tasigna Drug Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Tasigna Drug Sales by Type (2013-2018)
Table Middle East and Africa Tasigna Drug Sales Share by Type (2013-2018)
Table Middle East and Africa Tasigna Drug Revenue by Type (2013-2018)
Table Middle East and Africa Tasigna Drug Revenue Share by Type (2013-2018)
Table Middle East and Africa Tasigna Drug Sales by Application (2013-2018)
Table Middle East and Africa Tasigna Drug Sales Share by Application (2013-2018)
Table Middle East and Africa Tasigna Drug Revenue by Application (2013-2018)
Table Middle East and Africa Tasigna Drug Revenue Share by Application (2013-2018)
Table Global Tasigna Drug Sales by Type (2013-2018)
Table Global Tasigna Drug Sales Share by Type (2013-2018)
Table Global Tasigna Drug Revenue by Type (2013-2018)
Table Global Tasigna Drug Revenue Share by Type (2013-2018)
Figure Global 50mg Sales Growth (2013-2018)
Figure Global 50mg Price (2013-2018)
Figure Global 200mg Sales Growth (2013-2018)
Figure Global 200mg Price (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Other Price (2013-2018)
Table Global Tasigna Drug Sales by Application (2013-2018)
Table Global Tasigna Drug Sales Share by Application (2013-2018)
Figure Global Hospital Sales Growth (2013-2018)
Figure Global Drugs Store Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Tasigna Drug Sales, Revenue and Growth Rate (2018-2023)
Table Global Tasigna Drug Sales Forecast by Regions (2018-2023)
Table Global Tasigna Drug Market Share Forecast by Regions (2018-2023)
Figure North America Sales Tasigna Drug Market Forecast (2018-2023)
Figure Europe Sales Tasigna Drug Market Forecast (2018-2023)
Figure Asia-Pacific Sales Tasigna Drug Market Forecast (2018-2023)
Figure South America Sales Tasigna Drug Market Forecast (2018-2023)
Figure Middle East and Africa Sales Tasigna Drug Market Forecast (2018-2023)
Table Global Tasigna Drug Sales Forecast by Type (2018-2023)
Table Global Tasigna Drug Market Share Forecast by Type (2018-2023)
Table Global Tasigna Drug Sales Forecast by Application (2018-2023)
Table Global Tasigna Drug Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List